You just read:

VIVES Portfolio Company iTeos Therapeutics, a Spin-Off of UCL and LICR, Strengthened by an Oversubscribed Series B Fundraising of 64 Million Euros

News provided by

VIVES

20 Jun, 2018, 12:56 BST